Sort by
Refine Your Search
-
large proteins. Cultures with poor transfection efficiency do not generate enough signal for STD-NMR spectroscopy and this has hindered method development. We seek proposals aimed at determining
-
), in the CODATA evaluation of fundamental constants, and in more stringent tests of quantum electrodynamics (QED). Experimental efforts include the development of novel ion trap architectures
-
key component at this stage will be the development of quantum characterization protocols for spin qubits in the presence of time-correlated noise, as well as reliable tools for simulating the quantum
-
/ThreeBodyTB.jl), cluster expansion, classical potential development, and machine learning. In addition to work on specific problems, I work on developing new first principles-based modeling approaches, including
-
NIST only participates in the February and August reviews. The development of therapies and other products based on pluripotent stem cells requires control of the pluripotent and differentiated
-
to profile the microbial communities based on metagenomics and transcriptomics approaches. The comprehensive profiling methodologies will provide the foundation for the development of reference materials
-
and development of gene therapies. This NIST postdoctoral research opportunity focuses on developing robust protocols and refining measurement methods in infectious titer assays. Activities can include
-
. Opportunities are available in instrument development and automation, astronomical and atmospheric data analysis. Participation in more than one project is possible. Our Current Projects: NIST Stars: Motivated by
-
results. We are also pursuing advanced data analysis techniques and development of neutron instrumentation and sample environments in support of autonomous experimentation and high-throughput measurement
-
identification of spectral features by computer vision and machine learning. Our computational methods development has three primary goals. The first goal is continued support of expert-driven biomolecular